Clinical Trial

The DoHAICs Study Expansion Phase

Name: The DoHAICs Study Expansion Phase — clinical trial record (NCT07584018)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

We explored the efficacy and safety of the first-line treatment of unresectable hepatocellular carcinoma with donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab .

Trial Details

NCT Number	NCT07584018
Lead Sponsor	Tianjin Medical University Cancer Institute and Hospital
Conditions	HCC - Hepatocellular Carcinoma
Enrollment	90 participants
Start Date	2026-05-20
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-13